(Circulation. 1995;92:479-482.)
© 1995 American Heart Association, Inc.
Articles |
From the First Department of Surgery (Y.S., K.S., H.-Z.B., R.S., H.M.), the Department of Geriatric Medicine (R.M.), and the Department of the Institute for Molecular and Cellular Biology (Y.K.), Osaka University Medical School, Osaka, Japan.
Correspondence to Hikaru Matsuda, MD, First Department of Surgery, Osaka University Medical School, 2-2 Yamada-oka, Suita, Osaka 565, Japan.
Background Current methods of in vivo gene transfer into myocardium are limited by low efficiency. To improve in vivo gene transfer, a gene transfer method using hemagglutinating virus of Japan (HVJ) as a viral vector can be an alternative.
Methods and Results In vivo gene transfection of FITC-labeled oligonucleotide (F-ODN) and cDNA of ß-galactosidase (ß-gal) was examined with use of the HVJ liposome (H group) or without it (C group). In the H group, F-ODN or cDNA of ß-gal were complexed with liposomes, DNA binding nuclear protein (HMG1), and the viral protein coat of HVJ. After the harvest of donor rat hearts arrested by cardioplegia, the coronary artery was infused with the liposome gene complex. The hearts were transplanted into the abdomens of recipient rats and harvested 3 days after transplantation. Regarding F-ODN, the H group clearly showed FITC staining in the nuclei of the myocytes and endothelial cells in almost all layers of the myocardium as compared with the C group. Regarding the expression of ß-gal, the H group showed a clear expression of ß-gal on myocytes, whereas very low expression of ß-gal was seen in the C group.
Conclusions The donor hearts were transfected with F-ODN and ß-gal gene in almost all layers of the myocardium as a result of coronary infusion of the HVJ liposome during cardioplegic arrest. Our method is seen as a novel in vivo gene transfer technique for the heart and may provide a new tool for both research and therapy of heart transplantation.
Key Words: genes myocardium liposomes transplantation
This article has been cited by other articles:
![]() |
G. Vassalli, S. Fleury, J. Li, J.-J. Goy, L. Kappenberger, and L. K. von Segesser Gene transfer of cytoprotective and immunomodulatory molecules for prevention of cardiac allograft rejection Eur. J. Cardiothorac. Surg., November 1, 2003; 24(5): 794 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suzuki, B. Murtuza, N. Suzuki, M. Khan, Y. Kaneda, and M. H. Yacoub Human Cytomegalovirus Immediate-Early Protein IE2-86, but not IE1-72, Causes Graft Coronary Arteriopathy in the Transplanted Rat Heart Circulation, September 24, 2002; 106(12_suppl_1): I-158 - I-162. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nishizaki, O. Mazda, Y. Dohi, T. Kawata, K. Mizuguchi, S. Kitamura, and S. Taniguchi In vivo gene gun-mediated transduction into rat heart with Epstein-Barr virus-based episomal vectors Ann. Thorac. Surg., October 1, 2000; 70(4): 1332 - 1337. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sakaguchi, Y. Sawa, M. Kitakaze, K. Suzuki, M. Nishimura, Y. Kaneda, and H. Matsuda Ecto-5'-nucleotidase plays a role in the cardioprotective effects of heat shock protein 72 in ischemia-reperfusion injury in rat hearts Cardiovasc Res, July 1, 2000; 47(1): 74 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ueda, Y. Sawa, K. Matsumoto, S. Kitagawa-Sakakida, Y. Kawahira, T. Nakamura, Y. Kaneda, and H. Matsuda Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart Ann. Thorac. Surg., June 1, 1999; 67(6): 1726 - 1731. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Takeda, Y. Sawa, M. Minami, Y. Kaneda, Y. Fujii, R. Shirakura, M. Yanagisawa, and H. Matsuda Experimental Bronchiolitis Obliterans Induced by In Vivo HVJ-Liposome-Mediated Endothelin-1 Gene Transfer Ann. Thorac. Surg., June 1, 1997; 63(6): 1562 - 1567. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |